Adjunctive host-directed therapies for pulmonary tuberculosis: data from a prospective, open-label, phase 2, randomised controlled trial

The dataset was produced as part of a phase 2 randomised controlled trial of adults with pulmonary tuberculosis, conducted in South Africa (ClinicalTrials.gov, NCT02968927). It consists of 9 data tables from n=199 participants, randomised and who had taken at least one dose of treatment: [1] Adverse Event (AE) data, [2] Baseline data, [3] CRP measurement data, [4] Sputum culture results data, [5] PET CT Scan data, [6] Pulmonary Function Test (PFT) data, [7] Randomisation data, [8] Visit timings data, and [9] Whole blood assay (WBA) data.

Additional Information

Trial investigators and participants are committed to making anonymized patient-level data from this trial available to qualified researchers in a timely manner. Please contact us, including a description of the proposed research and your background, to begin this process.

Keywords

randomised control trials, Pulmonary Tuberculosis